RecruitingNCT06472557
Spinocerebellar Ataxia Type 27B Natural History Study (SCA27B-NHS)
Studying Spinocerebellar ataxia type 27B
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Tuebingen
- Principal Investigator
- Matthis Synofzik, Prof. Dr.University Hospital Tübingen
- Enrollment
- 300 enrolled
- Eligibility
- 18-99 years · All sexes
- Timeline
- 2024 – 2028
Study locations (4)
- Department of Neurology, Motol University Hospital, Second Faculty of Medicine, Charles University, Prague, Czechia
- Center for Neurology & Hertie-Institute for Clinical Brain Research, Dept. for Neurodegenerative Diseases, Tübingen, Baden-Wurttemberg, Germany
- Department of Neurology & Center for Translational Neuro- and Behavioral Sciences, Essen University Hospital, University of Duisburg-Essen, Essen, North Rhine-Westphalia, Germany
- Department of Neurology, Donostia University Hospital, BioGipuzkoa Health Research Institute, San Sebastián, Gipuzkoa, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06472557 on ClinicalTrials.gov